Skip to main content
. 2014 Dec 18;8:438. doi: 10.3389/fnbeh.2014.00438

Figure 4.

Figure 4

Expression of glutamate receptor subunits. GluN2B and GluA2 in the hippocampus (A,B) and dorsal striatum (C,D) 7 weeks after the first injection of MA or saline. The hippocampus shows significant increases in GluN2B with MA treatment (*p < 0.05) with a concomitant decrease in the dorsal striatum (**p < 0.01; A,C). GluA2 levels significantly decreased in the dorsal striatum after MA treatment (*p < 0.05) but did not significantly change between conditions in the hippocampus (D,B).